Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology International"
DOI: 10.1007/s12072-019-09977-w
Abstract: Background Activation of Wnt/β-catenin pathway is a frequent event in hepatocellular carcinoma and is associated with enhanced cell survival and proliferation. Therefore, targeting this signaling pathway is discussed as an attractive therapeutic approach for HCC… read more here.
Keywords: hepatocellular carcinoma; bcl9 bcl9l; hcc; wnt ... See more keywords
BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
Sign Up to like & getrecommendations! Published in 2020 at "Hepatology international"
DOI: 10.1007/s12072-020-10059-5
Abstract: In the past few decades, hepatocellular carcinoma (HCC) has emerged as the most rapidly rising cause of cancer-related mortality in the USA [1]. Even though we are gradually getting a grip on the traditional risk… read more here.
Keywords: hepatocellular carcinoma; bcl9 bcl9l; hcc; wnt ... See more keywords